Maravai Lifesciences Holdings annual depreciation and amortization
2019
2020
2021
2022
2023
2024
2025
Maravai Lifesciences Holdings Depreciation & Amortization Growth & History (MRVI)
Maravai Lifesciences Holdings's depreciation and amortization was $51.5M for fiscal 2025.
View full Maravai Lifesciences Holdings company overviewMaravai Lifesciences Holdings annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $51.5M | $3.1M | +6.46% |
| 2024 | 2024-12-31 | $48.4M | $8.1M | +20.19% |
| 2023 | 2023-12-31 | $40.3M | $8.4M | +26.45% |
| 2022 | 2022-12-31 | $31.8M | $7.1M | +28.62% |
| 2021 | 2021-12-31 | $24.8M | −$1.2M | −4.48% |
| 2020 | 2020-12-31 | $25.9M | $1.8M | +7.59% |
| 2019 | 2019-12-31 | $24.1M | — | — |
Maravai Lifesciences Holdings quarterly depreciation and amortization
Q1.20
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $11.8M | −$1.4M | −10.45% |
| Q1 2026 | 2026-03-31 | $11.4M | −$1.4M | −10.62% |
| Q4 2025 | 2025-12-31 | $14.7M | — | — |
| Q3 2025 | 2025-09-30 | $13.2M | $1.2M | +10.47% |
| Q2 2025 | 2025-06-30 | $13.2M | $732,000 | +5.89% |
| Q1 2025 | 2025-03-31 | $12.7M | $1.1M | +9.16% |
| Q3 2024 | 2024-09-30 | $11.9M | $994,000 | +9.09% |
| Q2 2024 | 2024-06-30 | $12.4M | $2.8M | +28.53% |
| Q1 2024 | 2024-03-31 | $11.7M | $2.8M | +31.77% |
| Q3 2023 | 2023-09-30 | $10.9M | $2.8M | +34.89% |
| Q2 2023 | 2023-06-30 | $9.7M | $1.5M | +18.70% |
| Q1 2023 | 2023-03-31 | $8.8M | $1.5M | +19.82% |
| Q3 2022 | 2022-09-30 | $8.1M | $1.7M | +26.71% |
| Q2 2022 | 2022-06-30 | $8.1M | $1.5M | +22.37% |
| Q1 2022 | 2022-03-31 | $7.4M | $1.1M | +17.23% |
| Q3 2021 | 2021-09-30 | $6.4M | −$270,000 | −4.05% |
| Q2 2021 | 2021-06-30 | $6.7M | $180,000 | +2.78% |
| Q1 2021 | 2021-03-31 | $6.3M | −$469,000 | −6.93% |
| Q3 2020 | 2020-09-30 | $6.7M | — | — |
| Q2 2020 | 2020-06-30 | $6.5M | — | — |
| Q1 2020 | 2020-03-31 | $6.8M | — | — |
Maravai Lifesciences Holdings depreciation and amortization trends
Over the last five fiscal years, Maravai Lifesciences Holdings's depreciation and amortization increased from $25.9M to $51.5M, a change of $25.6M. The latest reported quarter, Q2 2026, shows $11.8M.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Maravai Lifesciences Holdings source filings ↗